Head-to-head
Hims & Hers vs Ro (Ro Body)
Compared on both medications across the eight dimensions this database records. They differ on 4 of those eight. Hims & Hers is cheaper on all-in tirzepatide at 10 mg/week, though on a flat-versus-tiered matchup the cheaper program can change further up the dose ladder.
The short answer
Hims & Hers is $697 a month all-in for tirzepatide; Ro (Ro Body) is $747. Over twelve months that is $8,364 against $8,964. Value Scores are 27.5 and 26.3 out of 100.
Tirzepatide
Plan pages: Hims & Hers plans · Ro (Ro Body) plans
At 10 mg/week, Hims & Hers is $697 a month all-in and Ro (Ro Body) is $747 — $50 apart, or $600 across a year. Over twelve months the totals are $8,364 (billed monthly) and $8,964 (billed monthly).
Hims & Hers charges a flat $548 per month for tirzepatide at every dose from 2.5 to 15 mg per week, so titrating upward does not change what you pay. The company publishes no price at 5, 7.5, 12.5, 15 mg, so those doses are left blank rather than estimated.
Ro (Ro Body) prices tirzepatide by dose: $448 per month at 2.5 mg rising to $598 at 10 mg, a difference of $150 a month between the bottom and top of the ladder. The company publishes no price at 5, 7.5, 12.5, 15 mg, so those doses are left blank rather than estimated.
| Dose | Hims & Hers | Rank | Ro (Ro Body) | Rank | Cheaper |
|---|---|---|---|---|---|
| 2.5 mg | $548 | 30/31 | $448 | 29/31 | Ro (Ro Body) by $100 |
| 5 mg | — | — | — | — | neither publishes |
| 7.5 mg | — | — | — | — | neither publishes |
| 10 mg | $548 | 25/27 | $598 | 27/27 | Hims & Hers by $50 |
| 12.5 mg | — | — | — | — | neither publishes |
| 15 mg | — | — | — | — | neither publishes |
The lead changes with the dose. Between 2.5 mg and 10 mg it passes to Hims & Hers. Pick on the dose you expect to settle at, not the headline.
Across the 27 programs this database can rank on tirzepatide, Hims & Hers sits 25 of 27 on all-in monthly cost and Ro (Ro Body) sits 27. There is 1 other program priced between them. The field median is $339 and the floor is $169, so both sit above the median. Hims & Hers is $528 above the cheapest tirzepatide program on record. Ro (Ro Body) is $578 above the cheapest tirzepatide program on record.
LillyDirect (Zepbound), the lowest FDA-approved tirzepatide channel here, is $449 a month — Hims & Hers undercuts it by $-248, Ro (Ro Body) by $-298. Compounded products are not FDA approved; insurance can reverse that comparison.
| Plan term | Hims & Hers | Ro (Ro Body) | Cheaper |
|---|---|---|---|
| Month to month | $548 | $598 | Hims & Hers by $50 |
| Settled dose | Hims & Hers | Ro (Ro Body) | Difference |
|---|---|---|---|
| 2.5 mg | $8,364 | $7,164 | $1,200 apart |
| 10 mg | $8,364 | $8,964 | $600 apart |
Hims & Hers publishes no rate for 3-month term, 6-month term, 12-month term; Ro (Ro Body) publishes none for 3-month term, 6-month term, 12-month term. An unpublished term is not necessarily unavailable — it is unpriced in public, which you can only resolve by asking.
A titration year is not twelve months at the maintenance price. Stepping up roughly four weeks per dose before settling at 10 mg/week, the first twelve months work out to $8,364 on Hims & Hers and $8,814 on Ro (Ro Body) — $450 apart, and a different gap from the $600 you would get by multiplying the monthly difference by twelve. The ramp is cheaper than the settled rate on whichever program prices by dose, which is why a first-year quote and a steady-state quote are not the same number.
That calculation is partial: Hims & Hers publishes no price at 2 of the 6 doses and Ro (Ro Body) publishes no price at 2 of them, so the maintenance rate stands in for the missing steps rather than a number the company has stated.
Value Scores are 27.5 for Hims & Hers and 26.3 for Ro (Ro Body), against a tirzepatide category floor of $169. Hims & Hers leads by 1.2 points, driven mostly by price.
| Program | Price /70 | Evidence /15 | Dose /10 | Membership /5 | Total /100 |
|---|---|---|---|---|---|
| Hims & Hers | 17.0 | 10.5 | 0 | 0 | 27.5 |
| Ro (Ro Body) | 15.8 | 10.5 | 0 | 0 | 26.3 |
Semaglutide
Plan pages: Hims & Hers plans · Ro (Ro Body) plans
At 2.4 mg/week, Hims & Hers is $602 a month all-in and Ro (Ro Body) is $647 — $45 apart, or $540 across a year. Over twelve months the totals are $7,224 (billed monthly) and $7,764 (billed monthly).
Hims & Hers charges a flat $453 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay. The company publishes no price at 0.5, 1, 1.7 mg, so those doses are left blank rather than estimated.
Ro (Ro Body) prices semaglutide by dose: $298 per month at 0.25 mg rising to $498 at 2.4 mg, a difference of $200 a month between the bottom and top of the ladder. The company publishes no price at 0.5, 1, 1.7 mg, so those doses are left blank rather than estimated.
The lead changes with the dose. Between 0.25 mg and 2.4 mg it passes to Hims & Hers. Pick on the dose you expect to settle at, not the headline.
Value Scores are 25.5 for Hims & Hers and 24.5 for Ro (Ro Body), against a semaglutide category floor of $129. Hims & Hers leads by 1.0 points, driven mostly by price.
Where the two programs differ
All-in monthly
Hims & Hers is cheaper month to month — $697 against $747, a gap of $50 every month, or $600 across a year if both rates hold.
Commitment
Hims & Hers asks for Membership month-to-month ($39 first month); Ro (Ro Body) asks for Membership month-to-month ($39 first month; ~$74/mo prepaid annual). This is the dimension most likely to change which program is actually cheaper for you, because the lowest rates on both sides are usually attached to the longest terms.
Shipping
Hims & Hers bills shipping separately at $5; the other includes it.
Twelve-month cost
Over twelve months the totals are $8,364 for Hims & Hers and $8,964 for Ro (Ro Body). Hims & Hers is lower by $600 — a figure worth checking against the cancellation terms below, because a prepaid year is only cheaper if you stay on it.
Cancellation terms
Both state the same cancellation terms: Cancel anytime.
Dose policy
Both price by dose, so both advertised figures understate the cost of a titration year. Compare the ladders above rather than the headline rates.
Evidence status
Both figures carry the same evidence status, reported: sourced from dated third-party reporting; first-party capture pending. Neither is stronger than the other on provenance.
Membership fee
Hims & Hers charges a membership of $149 a month on top of the medication. That is already folded into the all-in figures above — it is broken out here because a membership is a recurring charge that continues even in a month you skip a shipment.
What each record says
Hims & Hers Official site
After settling with Novo Nordisk on March 9, 2026 and exiting compounded semaglutide for new patients, Hims & Hers now runs a branded-only GLP-1 service: Wegovy injection $299/month, oral Wegovy $249/month, and Zepbound $399/month, on top of a $149/month membership ($39 first month) plus $5 shipping.
It names its compounding pharmacy — Brand fulfillment (Wegovy, oral Wegovy, Zepbound) + partner pharmacy, recorded as Brand channel — which can be checked against state board licensing and FDA inspection records before you order; commitment terms are Membership month-to-month ($39 first month); cancellation is Cancel anytime; availability is stated as 50 states.
Evidence: reported — sourced from dated third-party reporting; first-party capture pending, captured . Source — Post-settlement pricing reported May–Jun 2026 (Wegovy $299 / oral $249 / Zepbound $399 + $149 membership + $5 shipping); first-party checkout capture pending
Watch: The membership is the number that moves the math: a $299 Wegovy pen becomes ~$453/month all-in. Compare against going to NovoCare or LillyDirect directly.
Ro (Ro Body) Official site
Ro exited compounded GLP-1s in 2026 and now pairs a $39-then-$149/month membership (about $74/month prepaid annually) with brand-only medication: Wegovy pill from $149, Wegovy pen from $199 promotional / $349 standard, and Zepbound from $299 to $449 by dose. Its insurance concierge — benefits checks, prior authorizations, appeals — is the strongest in the category and can take a covered patient to a $25 copay.
It names its compounding pharmacy — Brand fulfillment via NovoCare / LillyDirect pathways, recorded as Brand channel + insurance concierge — which can be checked against state board licensing and FDA inspection records before you order; commitment terms are Membership month-to-month ($39 first month; ~$74/mo prepaid annual); cancellation is Cancel anytime; availability is stated as 50 states.
Evidence: reported — sourced from dated third-party reporting; first-party capture pending, captured . Source — Ro pricing pages as reported Jul 2026 ($149 membership + Zepbound $299–$449 by dose); first-party checkout capture pending
Watch: Cash-pay all-in runs ~$448–$598/month at maintenance; Ro's value case is insurance navigation, not cash price.
What neither record tells you
Hims & Hers does not publish
- no tirzepatide price at 5, 7.5, 12.5, 15 mg per week
- no published twelve-month tirzepatide rate
- no semaglutide price at 0.5, 1, 1.7 mg per week
- no published twelve-month semaglutide rate
Ro (Ro Body) does not publish
- no tirzepatide price at 5, 7.5, 12.5, 15 mg per week
- no published twelve-month tirzepatide rate
- no semaglutide price at 0.5, 1, 1.7 mg per week
- no published twelve-month semaglutide rate
Ask Hims & Hers and Ro (Ro Body) for each of those in writing before enrolling. A gap is not evidence of a problem; it does mean nothing can be checked against it.
What would change this answer
Evidence may be upgraded. Hims & Hers, Ro (Ro Body) carry a price we have not captured at checkout. A capture would move the evidence term and could reorder these two without any price changing.
Which one suits which reader
On the lowest standing monthly rate for tirzepatide, Hims & Hers Official site wins this matchup. On the structural dimensions the two are close enough that the choice comes down to availability in your state and which intake you prefer.
Both figures should be checked at the provider's own checkout before you pay. Hims & Hers's tirzepatide price is reported as of 2026-08-11; Ro (Ro Body)'s is reported as of 2026-08-11.
Questions
Is Hims & Hers or Ro (Ro Body) cheaper for tirzepatide?
Hims & Hers is cheaper on all-in monthly cost at 10 mg/week: $697 against $747, a difference of $50 a month. All-in means the medication plus every mandatory recurring fee.
What is the twelve-month cost of Hims & Hers versus Ro (Ro Body)?
Hims & Hers works out to $8,364 across twelve months and Ro (Ro Body) to $8,964, on the plan terms each publishes.
Does Hims & Hers or Ro (Ro Body) raise the price as the dose goes up?
Hims & Hers: yes, it prices by dose. Ro (Ro Body): yes, it prices by dose. Where one program is flat and the other is tiered, the cheaper of the two can change as you titrate upward.
How many ways do Hims & Hers and Ro (Ro Body) differ?
4 of the eight dimensions this site records: all-in monthly, twelve-month cost, dose policy, membership, shipping, commitment, cancellation terms and evidence status.
Which of Hims & Hers and Ro (Ro Body) names its pharmacy?
Both do. Hims & Hers names Brand fulfillment (Wegovy, oral Wegovy, Zepbound) + partner pharmacy and Ro (Ro Body) names Brand fulfillment via NovoCare / LillyDirect pathways, so both can be checked against state board licensing and FDA inspection records.
How well evidenced are the Hims & Hers and Ro (Ro Body) prices?
Hims & Hers's tirzepatide figure is reported — sourced from dated third-party reporting; first-party capture pending — captured 2026-08-11. Ro (Ro Body)'s is reported, captured 2026-08-11. Evidence status is worth fifteen points in the Value Score, so it is priced in rather than mentioned as an aside.
Which is cheaper for semaglutide?
Hims & Hers, at $602 a month all-in against $647 at 2.4 mg/week. The two programs do not necessarily lead on both medications.
Official sources: Hims & Hers official site · Ro (Ro Body) official site. Compounded tirzepatide and semaglutide are not FDA-approved products.